CPT1A Arctic Variant: Difference between revisions

From Guide to YKHC Medical Practices

(Created page with "'''Carntitine Palmitoyl Transferase, Type 1A Arctic Variant (CPT1A Acrtic Variant)''' <br/>''(Adapted from Pocket-Guide-to-Alaska-Native-Pediatric-Diagnoses web.pdf|Pocket G...")
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 21: Line 21:
*Fasting or illness during first 2 years of life
*Fasting or illness during first 2 years of life
*fever, moderate/severe infection, dehydration, Surgery
*fever, moderate/severe infection, dehydration, Surgery
'''Resources:'''
===Resources/References===
* [[media:Arctic-Variant-CPT-1.pdf|The Arctic Variant of CPT-1A]] (Powerpoint Presentation by Matthew Hirschfeld,MD/PhD)
* [[media:Arctic-Variant-CPT-1.pdf|The Arctic Variant of CPT-1A]] (Powerpoint Presentation by Matthew Hirschfeld,MD/PhD)
*Newborn Screening Information for Parents:  https://www.newbornscreening.info/Parents/fattyaciddisorders/CPT1AV.html
*Newborn Screening Information for Parents:  https://www.newbornscreening.info/Parents/fattyaciddisorders/CPT1AV.html
Line 27: Line 27:
*[[media:cpt1-brochure.pdf|CPT1 Deficiency brochure]]
*[[media:cpt1-brochure.pdf|CPT1 Deficiency brochure]]
*Gillingham et al. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197793/ Impaired fasting tolerance among Alaska Native Children with a common Carnitine Palmitoyltransferase 1A sequence variant.] ''Molecular Genetics and Metabolism.'' 2011. doi: 10.1016/j.ymgme.2011.06.017.
*Gillingham et al. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197793/ Impaired fasting tolerance among Alaska Native Children with a common Carnitine Palmitoyltransferase 1A sequence variant.] ''Molecular Genetics and Metabolism.'' 2011. doi: 10.1016/j.ymgme.2011.06.017.
*YouTube: "[https://www.youtube.com/watch?v=ZBJB6gLAr4Q&feature=youtu.be CPT1A Arctic Variant for Health care providers] by David Koeller
[[Practicing Medicine in Bush Alaska—Some ABCs|Common/Unique Medical Diagnoses]]

Latest revision as of 21:59, 19 October 2020

Carntitine Palmitoyl Transferase, Type 1A Arctic Variant (CPT1A Acrtic Variant)
(Adapted from Pocket Guide to Alaska Native Pediatric Diagnoses)
Pathophysiology: Fatty acid oxidation disorder: difficulty breaking down fatty acids from both food and body fat.
Inheritance: Autosomal recessive
Demographics:

  • Considered to be the wild-type (normal) gene in the Yu'pik population in Alaska (50% are homozygous for the Arctic Variant)
  • Total incidence per year in newborns in Alaska =7%
  • Found at a higher rate in all circumpolar coastline populations including Inuit populations in Canada and Greenland and indigenous populations of northern Siberia
  • General population = <1/1,000,000 (general CPT1A deficiency)

Signs/Symptoms:

  • Most children never have symptoms, but if they do, symptoms are more likely to be seen in children <2 years old
  • Initial signs of metabolic crisis: sleepiness, irritability, poor appetite
  • Metabolic crisis: Hypoglycemia (hypoketotic), seizures due to hypoglycemia, Death (especially associated with a concomitant infectious disease, although rare)

Diagnosis: Alaska Newborn Screen (processed in Oregon) - added to screen in the fall of 2003.
Management:

  • Avoid fasting states
  • When healthy, children with CPT1A Arctic Variant should eat like any other child their age
  • When sick, if infants and toddlers are unable to tolerate glucose-containing fluids (Pedialyte, juice, sports drinks) or food for more than 6 to 8 hours, they should see a health care provider immediately to consider IV or NG glucose-containing fluids.
  • Children with CPT1A Arctic Variant who are NPO on IV fluids should always be on dextrose containing fluids (D5-NS or D5-1/2NS). A normal maintenance rate is all that is needed.

Critical Times for Affected Patients:

  • Fasting or illness during first 2 years of life
  • fever, moderate/severe infection, dehydration, Surgery

Resources/References

Common/Unique Medical Diagnoses